Product Overview
Tirzepatide Troches are a compounded sublingual troche formulation designed to support glycemic management and weight management under medical supervision.
This formulation contains Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, compounded into a flavored troche designed to dissolve between the cheek and gum or under the tongue.
Tirzepatide Troches may be suitable for individuals under professional care for:
- Support with type 2 diabetes management
- Weight management concerns
- Appetite and satiety regulation
- Metabolic health support
- Patients preferring a needle-free compounded format when prescribed
- Each pack is compounded to professional standards and supplied as directed.
What This Formulation Is Designed To Support
Tirzepatide Troches may help:
- Support appetite regulation and reduced food intake
- Support satiety and portion control
- Support glycemic control in type 2 diabetes as part of a broader plan
- Support weight management when combined with diet and exercise
- Support metabolic health markers
- It is formulated for use under medical supervision as part of a comprehensive plan.
How This Formulation Works
Each troche contains Tirzepatide:
- Tirzepatide – GIP / GLP-1 Receptor Agonist (Troche Base)
- Mimics natural incretin hormones GIP and GLP-1
- Supports glucose-dependent insulin secretion
- Helps reduce glucagon secretion when glucose is elevated
- Supports delayed gastric emptying and satiety signaling
- Supports appetite regulation via central pathways
- Compounded in a troche base designed for slow dissolution and mucosal absorption, bypassing the need for injection.
Benefits of This Formulation
This compounded formulation may offer:
- Dual GIP and GLP-1 pathway support
- Needle-free troche format
- Discreet and convenient administration
- Multiple strength options to support individualized titration as prescribed
- Professional-strength compounded preparation
Directions for Use
Use strictly as directed by your healthcare provider.
General guidance may include:
- For oral mucosal use only – do not swallow whole
- Place one troche between cheek and gum or under tongue and allow to dissolve completely
- Do not chew, crush, or swallow quickly
- Avoid eating, drinking, or rinsing mouth for 15-30 minutes after dissolution
- Take at the same time as directed, typically once daily or as prescribed
- Do not adjust dose without medical advice.
Do not change your dosage without medical guidance.
Important Safety Information
Before using, inform your healthcare provider if you:
- Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome
- Have history of pancreatitis
- Have history of severe gastrointestinal disease or gastroparesis
- Have kidney disease, diabetic retinopathy, or gallbladder disease
- Are using insulin, sulfonylureas, or other glucose-lowering medications
- Are pregnant, planning pregnancy, or breastfeeding
- Have allergy to any troche base ingredients, flavors, or sweeteners
- For prescription use only.
Possible Side Effects
Some individuals may experience:
- Nausea, mild mouth tingling or irritation
- Altered taste, dry mouth
- Diarrhea, constipation, abdominal discomfort
- Decreased appetite
- Headache
- If persistent mouth irritation, severe abdominal pain, signs of allergic reaction, or gallbladder symptoms occur, discontinue and seek medical advice.
Drug Interactions
Semaglutide/B12 may interact with:
- Other diabetes medications (risk of hypoglycemia)
- Oral medications affected by delayed gastric emptying
- Certain gastrointestinal drugs
Always inform your provider about all medications and supplements you are taking.
Pregnancy & Breastfeeding
This medication is not recommended during pregnancy or breastfeeding.
If you become pregnant while using this treatment, discontinue use and consult your healthcare provider immediately.
Storage Instructions
- Store below 25°C or as labeled, typically refrigerated
- Protect from heat, light, and moisture
- Keep tightly closed in original container
- Do not freeze unless directed
- Keep out of reach of children
- Use only until beyond-use date assigned by pharmacy.
Frequently Asked Questions
Is this a prescription product?
Yes. Compounded Tirzepatide Troches require a valid prescription.
Is this the same as injectable brand products?
No. Commercial brands are injectable and regulatory-approved. Compounded troches are custom oral mucosal preparations not evaluated by FDA/TGA for safety, efficacy, or bioequivalence.
Why a troche instead of injection?
Some patients and prescribers prefer a needle-free format. Absorption and effect may differ from injectable forms. Choice of dosage form is at prescriber discretion.
Disclaimer
Tirzepatide Troches are a compounded prescription formulation supplied under professional guidance. This information is for educational purposes and does not replace professional medical advice.
Reviews
There are no reviews yet.